{"result": "(\"entity\"<|>KANIS JA<|>PERSON<|>Kanis Ja is a researcher involved in a meta-analysis on smoking and fracture risk.)\n##\n(\"entity\"<|>JOHNELL O<|>PERSON<|>Johnell O is a researcher who co-authored a study on smoking and fracture risk.)\n##\n(\"entity\"<|>ODEN A<|>PERSON<|>Oden A is a researcher who contributed to the meta-analysis on smoking and fracture risk.)\n##\n(\"entity\"<|>JOHANSSON H<|>PERSON<|>Johansson H is a researcher involved in the study of smoking and fracture risk.)\n##\n(\"entity\"<|>DE LATE C<|>PERSON<|>De Late C is a researcher who co-authored the meta-analysis on smoking and fracture risk.)\n##\n(\"entity\"<|>EISMAN JA<|>PERSON<|>Eisman JA is a researcher who contributed to the meta-analysis on smoking and fracture risk.)\n##\n(\"entity\"<|>HALLSTRÖM H<|>PERSON<|>Hallström H is a researcher who studied coffee, tea, and caffeine consumption in relation to osteoporotic fracture risk.)\n##\n(\"entity\"<|>WOLK A<|>PERSON<|>Wolk A is a researcher involved in the study of caffeine consumption and fracture risk.)\n##\n(\"entity\"<|>GLYNN A<|>PERSON<|>Glynn A is a researcher who co-authored the study on caffeine consumption and fracture risk.)\n##\n(\"entity\"<|>MICHAËLSSON K<|>PERSON<|>Michaëlsson K is a researcher involved in the study of caffeine consumption and fracture risk.)\n##\n(\"entity\"<|>DAWSON-HUGHES B<|>PERSON<|>Dawson-Hughes B is a researcher who provided recommendations on vitamin D and calcium intake for bone health.)\n##\n(\"entity\"<|>WEAVER CM<|>PERSON<|>Weaver CM is a researcher who studied calcium requirements for physically active people.)\n##\n(\"entity\"<|>BROWN JP<|>PERSON<|>Brown JP is a researcher who contributed to the clinical practice guidelines for osteoporosis in Canada.)\n##\n(\"entity\"<|>JOSSE RG<|>PERSON<|>Josse RG is a researcher who co-authored the clinical practice guidelines for osteoporosis in Canada.)\n##\n(\"entity\"<|>BRYANT RJ<|>PERSON<|>Bryant RJ is a researcher who discussed the implications of new dietary reference intakes for calcium.)\n##\n(\"entity\"<|>STRAUB DA<|>PERSON<|>Straub DA is a researcher who reviewed calcium supplementation in clinical practice.)\n##\n(\"entity\"<|>BISCHOFF-FERRARI HA<|>PERSON<|>Bischoff-Ferrari HA is a researcher who conducted a trial on calcium supplementation and fracture risk.)\n##\n(\"entity\"<|>REESE JR<|>PERSON<|>Rees JR is a researcher who co-authored a study on calcium supplementation and fracture risk.)\n##\n(\"entity\"<|>GRAU MV<|>PERSON<|>Grau MV is a researcher involved in the study on calcium supplementation and fracture risk.)\n##\n(\"entity\"<|>BARRY E<|>PERSON<|>Barry E is a researcher who contributed to the study on calcium supplementation and fracture risk.)\n##\n(\"entity\"<|>GUI J<|>PERSON<|>Gui J is a researcher who co-authored a study on calcium supplementation and fracture risk.)\n##\n(\"entity\"<|>BARON JA<|>PERSON<|>Baron JA is a researcher involved in the study on calcium supplementation and fracture risk.)\n##\n(\"entity\"<|>SHIN CS<|>PERSON<|>Shin CS is a researcher who discussed the risks and benefits of calcium supplementation.)\n##\n(\"entity\"<|>QUESADA GÓMEZ JM<|>PERSON<|>Quesada Gómez JM is a researcher who wrote about nutrition and osteoporosis.)\n##\n(\"entity\"<|>URIBARRI J<|>PERSON<|>Uribarri J is a researcher who studied phosphorus homeostasis in health and chronic kidney disease.)\n##\n(\"entity\"<|>NOORI N<|>PERSON<|>Noori N is a researcher who studied dietary phosphorus management in chronic kidney disease.)\n##\n(\"entity\"<|>KALANTAR-ZADEH K<|>PERSON<|>Kalantar-Zadeh K is a researcher who discussed dietary phosphorus sources in chronic kidney disease treatment.)\n##\n(\"entity\"<|>MURPHY-GUTEKUNST L<|>PERSON<|>Murphy-Gutekunst L is a researcher who studied hidden phosphorus in popular beverages.)\n##\n(\"entity\"<|>SULLIVAN CM<|>PERSON<|>Sullivan CM is a researcher who studied the impact of food additives on hyperphosphatemia in renal patients.)\n##\n(\"entity\"<|>NATIONAL KIDNEY FOUNDATION<|>ORGANIZATION<|>The National Kidney Foundation provides clinical practice guidelines for bone metabolism and disease in chronic kidney disease.)\n##\n(\"entity\"<|>OSTEOPOROSIS INTERNATIONAL<|>ORGANIZATION<|>Osteoporosis International publishes research and guidelines related to osteoporosis and bone health.)\n##\n(\"entity\"<|>OSTEOPOROSIS SOCIETY OF CANADA<|>ORGANIZATION<|>The Osteoporosis Society of Canada provides clinical practice guidelines for osteoporosis management.)\n##\n(\"entity\"<|>AMERICAN JOURNAL OF CLINICAL NUTRITION<|>ORGANIZATION<|>The American Journal of Clinical Nutrition publishes research on nutrition and its impact on health.)\n##\n(\"entity\"<|>JAMA<|>ORGANIZATION<|>JAMA is a peer-reviewed medical journal that publishes research and clinical studies.)\n##\n(\"entity\"<|>CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY<|>ORGANIZATION<|>The Clinical Journal of the American Society of Nephrology publishes research related to kidney health.)\n##\n(\"relationship\"<|>KANIS JA<|>JOHNELL O<|>Kanis Ja and Johnell O co-authored a meta-analysis on smoking and fracture risk<|>8)\n##\n(\"relationship\"<|>KANIS JA<|>ODEN A<|>Kanis Ja and Oden A co-authored a meta-analysis on smoking and fracture risk<|>8)\n##\n(\"relationship\"<|>KANIS JA<|>JOHANSSON H<|>Kanis Ja and Johansson H co-authored a meta-analysis on smoking and fracture risk<|>8)\n##\n(\"relationship\"<|>KANIS JA<|>DE LATE C<|>Kanis Ja and De Late C co-authored a meta-analysis on smoking and fracture risk<|>8)\n##\n(\"relationship\"<|>KANIS JA<|>EISMAN JA<|>Kanis Ja and Eisman JA co-authored a meta-analysis on smoking and fracture risk<|>8)\n##\n(\"relationship\"<|>HALLSTRÖM H<|>WOLK A<|>Hallström H and Wolk A co-authored a study on caffeine consumption and fracture risk<|>8)\n##\n(\"relationship\"<|>HALLSTRÖM H<|>GLYNN A<|>Hallström H and Glynn A co-authored a study on caffeine consumption and fracture risk<|>8)\n##\n(\"relationship\"<|>HALLSTRÖM H<|>MICHAËLSSON K<|>Hallström H and Michaëlsson K co-authored a study on caffeine consumption and fracture risk<|>8)\n##\n(\"relationship\"<|>DAWSON-HUGHES B<|>WEAVER CM<|>Dawson-Hughes B and Weaver CM are researchers discussing calcium requirements for bone health<|>8)\n##\n(\"relationship\"<|>BROWN JP<|>JOSSE RG<|>Brown JP and Josse RG co-authored clinical practice guidelines for osteoporosis in Canada<|>8)\n##\n(\"relationship\"<|>BRYANT RJ<|>BROWN JP<|>Bryant RJ and Brown JP discussed dietary reference intakes for calcium<|>6)\n##\n(\"relationship\"<|>BISCHOFF-FERRARI HA<|>REESE JR<|>Bischoff-Ferrari HA and Rees JR co-authored a study on calcium supplementation and fracture risk<|>8)\n##\n(\"relationship\"<|>BISCHOFF-FERRARI HA<|>GRAU MV<|>Bischoff-Ferrari HA and Grau MV co-authored a study on calcium supplementation and fracture risk<|>8)\n##\n(\"relationship\"<|>BISCHOFF-FERRARI HA<|>BARRY E<|>Bischoff-Ferrari HA and Barry E co-authored a study on calcium supplementation and fracture risk<|>8)\n##\n(\"relationship\"<|>BISCHOFF-FERRARI HA<|>GUI J<|>Bischoff-Ferrari HA and Gui J co-authored a study on calcium supplementation and fracture risk<|>8)\n##\n(\"relationship\"<|>SHIN CS<|>NOORI N<|>Shin CS and Noori N are researchers discussing dietary phosphorus management in chronic kidney disease<|>6)\n##\n(\"relationship\"<|>URIBARRI J<|>NOORI N<|>Uribarri J and Noori N are researchers discussing phosphorus homeostasis in chronic kidney disease<|>6)\n##\n(\"relationship\"<|>MURPHY-GUTEKUNST L<|>SULLIVAN CM<|>Murphy-Gutekunst L and Sullivan CM are researchers discussing hidden phosphorus in beverages<|>6)\n##\n(\"relationship\"<|>NATIONAL KIDNEY FOUNDATION<|>OSTEOPOROSIS SOCIETY OF CANADA<|>Both organizations provide guidelines related to bone health and osteoporosis<|>7)\n##\n(\"relationship\"<|>NATIONAL KIDNEY FOUNDATION<|>CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY<|>Both organizations publish research related to kidney health<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: . Clin Sci ( Lond) 2007; 113: 233-41.\n\n11. Kanis Ja, Johnell O, Oden A, Johansson H, De Late C, Eisman JA, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005; 16: 155-62.\n\n12. Hallström H, Wolk A, Glynn A, Michaëlsson K. Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int 2006; 17: 1055-64.\n\n13. Dawson-Hughes B. Vitamin D and calcium: Recommended intake for bone health. Osteoporosis International 1998; 8:S30-34.\n\n14. Weaver CM. Calcium requirements of physically active people. AM J Clin Nutr 2000; 72 (supp.):579S-84S.\n\n15. Brown JP, Josse RG, for the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; Suppl 10:S1-34.\n\n16. Bryant RJ, et al. The new DRI for Ca, Implications for osteoporosis. 1999 J Am coll Nutr Vol.18 No.5.\n\n17. Straub, DA. Calcium Supplementation in Clinical Practice: A Review of Forms, Doses, and Indications. Nutr Clin Pract 2007; 22; 286\n\n18. Bischoff-Ferrari HA, Rees JR, Grau MV, Barry E, Gui J, Baron JA. Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial. Am J Clin Nutr 2008;87:1945-51.\n\n19. Shin CS, et al. The Risks and Benefits of Calcium Supplementation. Endocrinol Metab 2015; 30:27-34.\n\n20. Quesada Gómez JM, Nutrición y osteoporosis. Manual Práctico de Nutrición y Salud. Nutrición y Enfermedad.\n\n21. K/DOQI nutrition in chronic renal failure. Am J Kindey Dis 2000;35 (6 Suppl 2): 1-140.\n\n22. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007; 20(4):295-301.\n\n23. Noori N, Sims J, Koople JD, Shah A, Colman S, Shinaberger CS, et al. Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iran J Kidney Dis 2010; 42(2):89-100.\n\n24. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010; 5:519-30.\n\n25. Urribari J, Calvo MS. Hidden of phosphorus in de typical American diet: Does it matter in nephrology? Semen Dial. 2003; 16:186-8.\n\n26. Murphy-Gutekunst L. Hidden phosphorus in popular beverges. Nephrol Nurs J. 2005; 32:443-5.\n\n27. Coates PM, Blackman MR ,Cragg GM, Levine M, Moss J, White JD,. Encyclopedia of dietary supplements. New York, NY: Marcel Deker; 2005.\n\n28. Sullivan CM, Leon JB, Sehgan AR. Phosphorus containing foods additives and the accuracy of nutrients databases: implications for renal patients. J Ren Nutr 2007; 17(5):350-4.\n\n29. Arnaudas L, Caverni A, Lou LM, Vercet A, Gimeno JA, Moreno R, García-Mena M, Alvarez R, Cuberes M, Sahdalá L, Etaaboudi S, Pérez J. Grupo Investigación ERC Aragón. Instituto de Investigación Sanitaria Aragón. Revista Diálisis y Trasplante. Vol. 33: 51; 2012.\n\n30. Sullivan CM, Sayre SS, Leon JB, Machekano R, Love TE, Porter D et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease. A randomized controlled trial. JAMA 2009; 301:629-35.\n\n31. National kindey Fundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(4 suppl 3):S1—202.\n\n32. Carvalho AB, Cuppari L. Controle da hiperfosfatemia na DRC. J Bras Nefrol 2011; 33(2): 191-6.\n\n33. Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc. Nephrol 2010; 5:683-92.111.\n\n34. Barril G, Puchulu B, Sánchez JA. Tablas ratio fósforo/pro\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}